CHAMBERS MICHAEL ANDREW purchased 11.1% of their position (23.69K shares) of SAREPTA THERAPEUTICS, INC. on the open market
Open‑market purchase worth $2.56M — a moderate purchase. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 8/14/2023ACC: 0001209191-23-045498
Director
Since Jun 2022
+23.69K
Net shares
Net buyer
$2.56M
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
23.69K acquired
Non-Derivative Transactions1
Common Stock
Indirect
Shares
+23.69K
Price / share
$108.05
Trade value
$2.56M
% of position
11.1%
8/11/2023
213.33K→237.02K
Total
Net shares
+23.69K
Net value
$2.56M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 8/11/2023 | P · Purchase | +23.69K | $108.05 | $2.56M | 11.1% | 213.33K | 237.02K |
| Total | +23.69K | $2.56M | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
DirectShares owned6.43K
Total
6.43K direct6.43K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 6.43K | Direct |
| Total | 6.43K | 6.43K direct |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported